CFTC’s crypto push meets CME’s lawsuit threat

The CFTC is opening more crypto products while CME prepares a legal fight over perpetual futures.

The latest clash in U.S. crypto regulation now has four moving parts: new CFTC support for more products, a push to work with the SEC, fresh relief for risk-reduction services, and CME Group’s plan to sue over perpetual futures approvals.

1. CFTC’s broader crypto product push

CFTC Chair Mike Selig said the agency wants to bring more crypto futures, perpetuals, and related products to market in the U.S. He framed the effort as a way to keep the country competitive and reduce the regulatory fights that slowed earlier product launches.

The key point is not just that the agency is approving more activity. It is also signaling that products once treated as too messy or too novel may now have a clearer path if regulators can agree on definitions and oversight.

• Security futures
• Security perpetuals
• Other crypto-linked assets

2. The SEC-CFTC coordination effort

Selig said the CFTC is working with the U.S. SEC and Chair Paul Atkins to stop the turf wars that previously blocked new products. That matters because crypto firms have long faced two overlapping rulebooks, which made compliance slower and more expensive.

The message from the agency is that different asset types should not be trapped in old jurisdiction fights. If the harmonization effort holds, issuers and exchanges may get a more predictable route for listing products that sit between securities and commodities.

• Joint rule alignment
• Clearer asset classification
• Fewer duplicate approvals

3. No-action relief for risk-reduction services

The CFTC also highlighted a no-action letter for swap post-trade risk reduction services, including portfolio rebalancing and basis risk mitigation. Selig argued that market participants should not face heavy requirements for actions that lower risk rather than add it.

That detail may sound technical, but it matters for desks that manage exposure across multiple products. Relief here could reduce friction for firms that need to rebalance positions quickly without triggering extra compliance costs.

4. CME’s lawsuit threat over perpetual futures

At the same time, CME Group said it plans to sue the CFTC over approvals tied to perpetual futures, with outgoing CEO Terry Duffy saying the filing could come as soon as June 18. CME argues perpetuals should be treated as swaps under the Dodd-Frank Act, not as standard futures contracts.

This is the sharpest conflict in the story. The CFTC is widening access to crypto perps, while CME says those approvals may cross a legal line. That sets up a direct test of how far the regulator can go in redefining product categories.

• Target: CFTC approval of perpetual futures
• Legal theory: perps should be swaps
• Market backdrop: competition with crypto-native venues

5. Why the Kalshi and Coinbase approvals matter

The dispute is not abstract. The CFTC has already approved perpetual futures tied to assets such as Bitcoin, ETH, XRP, SOL, and HYPE on Kalshi, and it has also approved perpetual futures activity involving Coinbase. Those decisions show the regulator is willing to let more crypto derivatives into the market.

For traders and exchanges, the practical question is whether this becomes a one-off burst of approvals or the start of a wider shift. If the CFTC keeps opening the door, more venues may seek similar treatment, and incumbents like CME may keep pushing back.

How to decide

If you want the policy signal, focus on the CFTC’s product expansion and SEC coordination. If you care about legal risk, watch CME’s lawsuit and whether the court accepts its swap argument. If you run a trading desk, the no-action relief may be the most immediately useful item because it affects operational friction, not just headlines.

For the broader market, the main takeaway is simple: U.S. crypto derivatives are moving toward more access, but the fight over who gets to define those products is not over.